Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

MRL Ventures Fund

MRL Ventures Fund
VC INVESTOR TYPE
Active STATUS
5 PROFESSIONALS
20 INVESTMENTS
10 PORTFOLIO
5 EXITS
Description

MRL Ventures Fund is a venture capital firm that invests in the early-stage innovative therapeutics companies that are developing transformative medicines. The firm is based in Cambridge, Massachusetts.

Website
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • 320 Bent Street
  • 4th Floor
  • Cambridge, MA 02141
  • United States

MRL Ventures Fund Investments (20)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Imago BioSciences 21-Mar-2019 Later Stage VC 0000 Biotechnology Clinical Trials - Phase 2
00000000 000000000 26-Nov-2018 00000 00000 0000 Drug Discovery Startup 0000 00000 00.0
000000 13-Nov-2018 00000 00000 0000 Biotechnology Generating Revenue
0000000 25-Jul-2018 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 000000 0000000 00
0000000 0000000000 27-Jun-2018 00000 00000 0000 Biotechnology Startup
0000 000000000000 23-May-2018 00000 00000 000.00 Biotechnology Product Development 0000 00000 00.0
000000000000 14-May-2018 00000 00000 0000 Pharmaceuticals Startup
00000000 05-Oct-2017 00000 00000 000.00 Biotechnology Generating Revenue 000000 0000000 00
LifeMine Therapeutics 15-Sep-2017 Early Stage VC 000.00 Pharmaceuticals Startup
Spero Therapeutics 08-Mar-2017 Later Stage VC 000.00 Biotechnology Generating Revenue/Not Profitable 0000 00000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore MRL Ventures Fund’s full profile, request a free trial.

MRL Ventures Fund Exits (5)

Company Name Exit Date Exit Type Exit Size Status Buyers
Alector 07-Feb-2019 IPO 00000 Completed
00000000 31-Aug-2018 000000000000000000 00000 Completed
  • 000000 00000000000
000000000 000 28-Jun-2018 000 00000 Completed
Spero Therapeutics 02-Nov-2017 IPO 0000 Completed
miRagen Therapeutics 14-Aug-2017 Secondary Transaction - Stock Distribution Completed
To view this investor’s complete exits history, request access »

MRL Ventures Fund Team (6)

Name Title Deals Funds Boards Office Contact
Info
Reza Halse Ph.D President 0 0 0 Cambridge, MA
Christine Brennan Ph.D Partner 0 Cambridge, MA
Peter Dudek Ph.D Partner Cambridge, MA
Diana Bernstein Ph.D Senior Associate Cambridge, MA
Olga Danilchanka Senior Associate Cambridge, MA

1 Former Team Member

You’re viewing 5 of 6 team members. Get the full list »

MRL Ventures Fund Co-Investors (85)

Name With Exits Lead Partner
Amgen Ventures 4 0 0
Atlas Venture 0 0 0
GV 0 0
Merck Capital Ventures 0 0 0
Omega Fund 0 0 0
To view this investor’s complete co-investor history, request access »